Immunohistochemical prognostic markers in intracranial ependymomas: Systematic review and meta-analysis

Pathology and Oncology Research

Volumn 15, Issue 4, 2009, Pages 605-614

  Kuncova, Klara ^a   Janda, Ales ^a   Kasal, Pavel ^a   Zamecnik, Josef ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Ependymoma; Immunohistochemistry; Ki 67; Meta analysis; MIB 1; Prognosis

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE P1; GLYCOPROTEIN P; KI 67 ANTIGEN; METALLOTHIONEIN; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53; TENASCIN; VASCULOTROPIN;

ALGORITHM; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; EPENDYMOMA; HUMAN; IMMUNOHISTOCHEMISTRY; OVERALL SURVIVAL; PROGNOSIS; RELIABILITY; SYSTEMATIC REVIEW;

BRAIN NEOPLASMS; EPENDYMOMA; HUMANS; KI-67 ANTIGEN; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 75049083676     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9160-2     Document Type: Article

References (49)

1. McLendon RE, Wiestler OD, Kros JM, Korshunov A, Ng HK (2007) Ependymoma. In: Louis DN, Wiestler OD, Cavanee WK (eds) Classification of the Tumours of the Central Nervous System. Lyon, International Agency for Research on Cancer (IARC)
2. NK Foreman S Love R Thorne 1996 Intracranial ependymomas: analysis of prognostic factors in a population-based series Pediatr Neurosurg 24 119 25 10.1159/000121027 1:STN:280:DyaK2s%2FitlKmtw%3D%3D 8870014
3. IF Pollack PC Gerszten AJ Martinez KH Lo B Shultz AL Albright J Janosky M Deutsch 1995 Intracranial ependymomas of childhood: long-term outcome and prognostic factors Neurosurgery 37 655 66 1:STN:280:DyaK287hslaisA%3D%3D 8559293
4. Bouffet E, Perilongo G, Canete A, Massimino M (1998) Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30: 319-29; discussion 329-31
5. PL Robertson PM Zeltzer JM Boyett, et al. 1998 Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group J Neurosurg 88 695 703 10.3171/jns.1998.88.4.0695 1:STN:280:DyaK1c7osVKhuw%3D%3D 9525716
6. J Zamecnik M Snuderl T Eckschlager, et al. 2003 Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors Mod Pathol 16 980 91 10.1097/01.MP.0000087420.34166.B6 14559980 (Pubitemid 37280813)
7. E Kurt PP Zheng WC Hop, et al. 2006 Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas Cancer 106 388 95 10.1002/cncr.21608 16342252 (Pubitemid 43100449)
8. L Bennetto N Foreman B Harding, et al. 1998 Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas Neuropathol Appl Neurobiol 24 434 40 10.1046/j.1365-2990.1998.00143.x 1:STN:280: DyaK1M7gsFWjsg%3D%3D 9888153 (Pubitemid 29002274)
9. Khan KS, ter Riet G, Glanville J, Sowden AJ, Kleijnen J (2001) Undertaking Systematic Reviews of Research on Effectiveness: CRD Guidelines for Those Carrying Out or Commissioning Reviews. CRD Report 4, NHS Centre for Reviews and Dissemination, University of York, York
10. MK Parmar V Torri L Stewart 1998 Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 2815 34 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 1:STN:280:DyaK1M7itVWksA%3D%3D 9921604 (Pubitemid 28562978)
11. Machin D, Cheung YB, Parmar MK (2006) Survival Analysis. A Practical Approach, 2nd edn. John Wiley, Chichester
12. RD Riley KR Abrams AJ Sutton, et al. 2003 Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future Br J Cancer 88 1191 8 10.1038/sj.bjc.6600886 1:STN:280:DC%2BD3s7nvVGhug%3D%3D 12698183 (Pubitemid 36606332)
13. RD Riley D Heney DR Jones, et al. 2004 A systematic review of molecular and biological tumor markers in neuroblastoma Clin Cancer Res 10 4 12 10.1158/1078-0432.CCR-1051-2 1:CAS:528:DC%2BD2cXkvF2rsA%3D%3D 14734444 (Pubitemid 38114154)
14. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F (2000) Methods for Meta-analysis in Medical Research. John Wiley and Sons, Ltd, Chichester
15. CE Rawlings F Giangaspero PC Burger DE Bullard 1988 Ependymomas: a clinicopathologic study Surg Neurol 29 271 81 10.1016/0090-3019(88)90158-9 3353839 (Pubitemid 18096072)
16. R Schroder C Ploner RI Ernestus 1993 The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index Neurosurg Rev 16 145 50 10.1007/BF00258248 1:STN:280: DyaK3szkslyhsA%3D%3D 8345908
17. H Takeuchi T Kubota K Sato JF Llena A Hirano 2002 Epithelial differentiation and proliferative potential in spinal ependymomas J Neurooncol 58 13 9 10.1023/A:1015844704632 12160136 (Pubitemid 34711967)
18. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 88 10.1016/0197-2456(86)90046-2 1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833 (Pubitemid 17189972)
19. U Tabori J Ma M Carter, et al. 2006 Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma J Clin Oncol 24 1522 8 10.1200/JCO.2005.04.2127 1:CAS:528: DC%2BD28XjvFyktro%3D 16575002 (Pubitemid 46638773)
20. MJ Verstegen DT Leenstra H Ijlst-Keizers DA Bosch 2002 Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis J Neurooncol 56 21 8 10.1023/A:1014471714058 1:STN:280: DC%2BD383htl2gtA%3D%3D 11949823 (Pubitemid 34256614)
21. S Wolfsberger I Fischer R Hoftberger, et al. 2004 Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma Am J Surg Pathol 28 914 20 10.1097/00000478-200407000-00011 15223962 (Pubitemid 38856848)
22. J Zamecnik M Chanova M Tichy R Kodet 2004 Distribution of the extracellular matrix glycoproteins in ependymomas-an immunohistochemical study with follow-up analysis Neoplasma 51 214 22 1:CAS:528:DC%2BD2cXlslGrsLo%3D 15254676
23. S Shuangshoti EJ Rushing H Mena C Olsen GD Sandberg 2005 Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients Cancer 103 2598 605 10.1002/cncr.21111 15861411 (Pubitemid 40800540)
24. D Schiffer P Cavalla A Migheli MT Giordana L Chiado-Piat 1996 Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study J Neurooncol 27 101 9 10.1007/BF00177472 1:STN:280:DyaK283jsVOlsA%3D%3D 8699231
25. D Schiffer A Chio MT Giordana T Pezzulo MC Vigliani 1993 Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study Acta Neuropathol (Berl) 85 495 502 10.1007/BF00230488 1:STN:280:DyaK3s3mt12ntg%3D%3D
26. AR Rezai HH Woo M Lee H Cohen D Zagzag FJ Epstein 1996 Disseminated ependymomas of the central nervous system J Neurosurg 85 618 24 10.3171/jns.1996.85.4.0618 1:STN:280:DyaK28vgvFWrsQ%3D%3D 8814165
27. AM Ritter KR Hess RE McLendon LA Langford 1998 Ependymomas: MIB-1 proliferation index and survival J Neurooncol 40 51 7 10.1023/A:1006082622699 1:STN:280:DyaK1M%2FovFGrsA%3D%3D 9874186 (Pubitemid 28548372)
28. AA Roma RA Prayson 2006 Expression of cyclo-oxygenase-2 in ependymal tumors Neuropathology 26 422 8 10.1111/j.1440-1789.2006.00714.x 17080719 (Pubitemid 44454412)
29. RA Prayson 1998 Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases Am J Clin Pathol 110 629 34 1:STN:280:DyaK1M%2Fhslegtg%3D%3D 9802348
30. RA Prayson 1999 Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry Ann Diagn Pathol 3 11 8 10.1016/S1092-9134(99)80004-5 1:STN:280:DyaK1M7ksFKmtg%3D%3D 9990108
31. M Preusser S Wolfsberger T Czech I Slavc H Budka JA Hainfellner 2005 Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome Am J Clin Pathol 124 543 9 10.1309/PP2G5GAAFKV82DTG 1:CAS:528:DC%2BD2MXhtFChsbbK 16146813
32. M Preusser S Wolfsberger C Haberler, et al. 2005 Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival Acta Neuropathol (Berl) 109 211 6 10.1007/s00401-004-0938-8 1:CAS:528:DC%2BD2MXis1Oktb8%3D (Pubitemid 40468391)
33. T Nagashima T Hoshino KG Cho MS Edwards RJ Hudgins RL Davis 1988 The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling Cancer 61 2433 8 10.1002/1097-0142(19880615)61: 12<2433::AID-CNCR2820611207>3.0.CO;2-A 1:STN:280:DyaL1c3htVahsw%3D%3D 3284636 (Pubitemid 18152610)
34. A Korshunov R Sycheva V Timirgaz A Golanov 1999 Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases J Neurooncol 45 219 27 10.1023/A:1006369829576 1:STN:280:DC%2BD3czgt1SjsA%3D%3D 10845392 (Pubitemid 30315739)
35. A Korshunov V Timirgaz A Golanov 1999 Prognostic value of aberrant p53 immunoexpression for the recurrence of ependymoma: An analysis of 76 cases Neuropathology 19 380 385 10.1046/j.1440-1789.1999.00254.x (Pubitemid 30032377)
36. A Korshunov A Golanov V Timirgaz 2001 p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases Acta Neuropathol (Berl) 102 271 7 1:CAS:528: DC%2BD3MXmtFKnsbc%3D
37. A Korshunov A Golanov V Timirgaz 2002 Immunohistochemical markers for prognosis of ependymal neoplasms J Neurooncol 58 255 70 10.1023/A:1016222202230 12187959 (Pubitemid 34830636)
38. DM Ho CY Hsu TT Wong H Chiang 2001 A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma J Neurooncol 54 77 85 10.1023/A:1012590505236 1:STN:280: DC%2BD38%2Fjtl2qtQ%3D%3D 11763426 (Pubitemid 33089263)
39. J Guyotat J Champier A Jouvet, et al. 2001 Differential expression of somatostatin receptors in ependymoma: implications for diagnosis Int J Cancer 95 144 51 10.1002/1097-0215(20010520)95:3<144::AID-IJC1025>3.0.CO;2-W 1:CAS:528:DC%2BD3MXjvFOmsbs%3D 11307146 (Pubitemid 32477228)
40. RJ Gilbertson L Bentley R Hernan, et al. 2002 ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease Clin Cancer Res 8 3054 64 1:CAS:528:DC%2BD38XosFKhsrw%3D 12374672
41. D Figarella-Branger M Civatte C Bouvier-Labit, et al. 2000 Prognostic factors in intracranial ependymomas in children J Neurosurg 93 605 13 10.3171/jns.2000.93.4.0605 1:STN:280:DC%2BD3cvmt1CrtQ%3D%3D 11014538
42. Figarella-Branger D, Gambarelli D, Dollo C et al. (1991) Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol (Berl) 82: 208-16
43. FF Cruz-Sanchez M Garcia-Bachs ML Rossi, et al. 1992 Epithelial differentiation in gliomas, meningiomas and choroid plexus papillomas Virchows Arch B Cell Pathol Incl Mol Pathol 62 25 34 10.1007/BF02899662 1:STN:280:DyaK38zht1Wjug%3D%3D 1352072
44. A Asai T Hoshino MS Edwards RL Davis 1992 Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index Childs Nerv Syst 8 273 8 10.1007/BF00300795 1:STN:280:DyaK3s%2FgvVSmsw%3D%3D 1394266
45. A Athanasiou B Perunovic RD Quilty VG Gorgoulis C Kittas S Love 2003 Expression of mos in ependymal gliomas Am J Clin Pathol 120 699 705 10.1309/DL2TLDJG7JB1BQ72 1:CAS:528:DC%2BD3sXpsVOnsL4%3D 14608895
46. Egger M, Davey Smith G, Altman D (2001) Systematic Reviews in Health Care: Meta-Analysis in Context. BMJ, London
47. CH Rickert W Paulus 2005 Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence Acta Neuropathol (Berl) 109 69 92 10.1007/s00401-004-0959-3 1:CAS:528:DC%2BD2MXhsVaksrc%3D (Pubitemid 40287791)
48. DG Altman GH Lyman 1998 Methodological challenges in the evaluation of prognostic factors in breast cancer Breast Cancer Res Treat 52 289 303 10.1023/A:1006193704132 1:STN:280:DyaK1M7mtl2ksw%3D%3D 10066088 (Pubitemid 29056101)
49. DJ Hutchon 2001 Publishing raw data and real time statistical analysis on e-journals Bmj 322 7285 530 10.1136/bmj.322.7285.530 1:STN:280: DC%2BD3M7pvVOhsw%3D%3D 11230070